Please assess the completion status of the following clinical trial:

Trial Title: Adhesion of Lidocaine Topical System 1.8%

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Must be healthy based on by medical history, laboratory work, and physical exam~* Be at least 18 years of age~* If childbearing potential, use of acceptable form of birth control~* In the case of females of childbearing potential, have a negative serum pregnancy test~Key Exclusion Criteria:~* Allergy or known hypersensitivity to lidocaine, amide-type local anesthetics, or any component of the product formulation~* Any major medical illness 3 months prior or any significant history or ongoing chronic medical illness~* Subjects with conditions that might affect application of the product or its adhesive properties (including psoriasis, eczema, atopic dermatitis, damaged or irritated epidermal layer, and excessive hair or oil on the skin)~* History of addiction, abuse, and misuse of any drug

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Lidocaine Patch (Type: EXPERIMENTAL): All subjects received one lidocaine topical system, which was applied to a predetermined fixed area on subject's left side of the back or right side of the back (lower/mid back) according to randomization schedule and worn for 12 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).